Close

Cytokinetics (CYTK) Presents Additional Omecamtiv Mecarbil Phase 2 Data; Improvement in LA Structure, Function Noted

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/26/2024

1. META
2. CMG
3. LRCX
4. IBM
5. SPY
6. BA
7. HCP
8. SNAP
9. TMUS
10. GOOGL


Go back to Cytokinetics (CYTK) Presents Additional Omecamtiv Mecarbil Phase 2 Data; Improvement in LA Structure, Function Noted

Cytokinetics Announces Presentation of Additional Results From COSMIC-HF at the AHA Annual Scientific Meeting

November 14, 2016 4:00 PM EST

Data Show Omecamtiv Mecarbil Improved Measures of Left Atrial Structure and Function

SOUTH SAN FRANCISCO, Calif., Nov. 14, 2016 (GLOBE NEWSWIRE) -- Cytokinetics, Inc. (Nasdaq: CYTK) today announced that additional results from COSMIC-HF (Chronic Oral Study of... More